71 Johnson & Johnson Earnings & Revenue Statistics (2022)

January 27, 2022

71 Johnson & Johnson Earnings & Revenue Statistics (2022)

Did you know that Johnson & Johnson generated $82.584 billion revenue in 2020? Find more Johnson & Johnson statistics in this study.

You’re about to see a list of up-to-date Johnson & Johnson earnings statistics.

All of the statistics we’ve compiled are current and up-to-date.

Keep reading to find new stats, facts, and trends related to:

Johnson & Johnson earnings
Johnson & Johnson annual & quarterly revenue
Johnson & Johnson profit
Johnson & Johnson stock price history
Johnson & Johnson market cap
Johnson & Johnson employees
A whole lot more

Let’s see some stats!

Key Johnson & Johnson Statistics

Through the first 3 quarters in 2021, Johnson & Johnson’s annual revenue was $68.971 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly revenue was $23.338 billion.
Johnson & Johnson's net worth as of January 21, 2022 is $434.04 billion.
Through the first 3 quarters of 2021, Johnson & Johnson’s gross profit was $47.071 billion.
In 2020, Johnson & Johnson had 134,500 employees.
The all time high Johnson & Johnson (JNJ) closing price for a stock was $179.47 on 8/17/2021.
As of January 2022, Johnson & Johnson’s market cap is $441.85 billion.
Johnson & Johnson’s operating income for the first 3 quarters of 2021 was $17.940 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly EBITDA was $5.696 billion, a 9.23% decline year-over-year.
During the first 3 quarters of 2021, Johnson & Johnson’s net income was $16.142 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly EPS was $1.37, a 3.01% increase year-over-year.
In Q3 of 2021, Johnson & Johnson’s shares outstanding were 2.675 billion, a 0.21% increase year-over-year.
In Q3 of 2021, Johnson & Johnson’s total assets were $179.228 billion, a 5% increase year-over-year.

Overview Of Johnson & Johnson

Company Name	Johnson & Johnson
2020 Revenue	$82.584 billion
2020 Net Income	$14.714 billion
Valuation	$434.04 billion
Launch Date	January 1886
HQ	New Brunswick, NJ
Founder	James Wood Johnson
Subsidiaries	Janssen Pharmaceuticals, Ethicon Inc.

Chapter 1: Johnson & Johnson Revenue Statistics

Johnson & Johnson Annual Revenue

Year	Annual Revenue
2020	$82.584 billion
2019	$82.059 billion
2018	$81.581 billion
2017	$76.450 billion
2016	$71.890 billion
2015	$70.074 billion
2014	$74.331 billion
2013	$71.312 billion
2012	$67.224 billion
2011	$65.030 billion
2010	$61.587 billion
2009	$61.897 billion
2008	$63.747 billion
2007	$61.095 billion
2006	$53.324 billion
2005	$50.514 billion

Through the first 3 quarters in 2021, Johnson & Johnson’s annual revenue was $68.971 billion.
In 2020, Johnson & Johnson’s annual revenue was $82.584 billion, a 0.64% increase from 2019.
In 2019, Johnson & Johnson’s annual revenue was $82.059 billion, a 0.59% increase from 2018.
In 2018, Johnson & Johnson’s annual revenue was $81.581 billion, a 6.71% increase from 2017.
In 2017, Johnson & Johnson’s annual revenue was $76.45 billion.
In 2016, Johnson & Johnson’s annual revenue was $71.89 billion.
In 2015, Johnson & Johnson’s annual revenue was $70.074 billion.
In 2014, Johnson & Johnson’s annual revenue was $74.331 billion.
In 2013, Johnson & Johnson’s annual revenue was $71.312 billion.
In 2012, Johnson & Johnson’s annual revenue was $67.224 billion.
In 2011, Johnson & Johnson’s annual revenue was $65.03 billion.
In 2010, Johnson & Johnson’s annual revenue was $61.587 billion.
In 2009, Johnson & Johnson’s annual revenue was $61.897 billion.
In 2008, Johnson & Johnson’s annual revenue was $63.747 billion.
In 2007, Johnson & Johnson’s annual revenue was $61.095 billion.
In 2006, Johnson & Johnson’s annual revenue was $53.324 billion.
In 2005, Johnson & Johnson’s annual revenue was $50.514 billion.
Johnson & Johnson brought in the most revenue in 2020, $82.584 billion.

Johnson & Johnson Quarterly Revenue

In Q3 of 2021, Johnson & Johnson’s quarterly revenue was $23.338 billion.
In Q2 of 2021, Johnson & Johnson’s quarterly revenue was $23.312 billion.
In Q1 of 2021, Johnson & Johnson’s quarterly revenue was $22.321 billion.
In Q4 of 2020, Johnson & Johnson’s quarterly revenue was $22.475 billion.
In Q3 of 2020, Johnson & Johnson’s quarterly revenue was $21.082 billion.
In Q2 of 2020, Johnson & Johnson’s quarterly revenue was $18.336 billion.
In Q1 of 2020, Johnson & Johnson’s quarterly revenue was $20.691 billion.
In Q3 of 2021, Johnson & Johnson’s brought in their most revenue, $23.38 billion, a 10.7% increase year-over-year.
During the 12 months between Q3 2020 - Q3 2021, Johnson & Johnson’s total revenue was $91.446 billion, a 13.1% increase year-over-year.
The 13.1% increase in revenue year-over-year from Q3 2020 - Q3 2021, was Johnson & Johnson’s biggest percentage increase year-over-year.

Johnson & Johnson Gross Profit

In 2020, Johnson & Johnson’s annual gross profit was $54.157 billion, a 0.63% decline from 2019.
In 2019, Johnson & Johnson’s gross annual profit was $54.503 billion, a 0.02% increase from 2018.
In 2018, Johnson & Johnson’s gross annual profit was $54.49 billion, a 6.82% increase from 2017.
In 2017, Johnson & Johnson’s annual gross profit was $51.011 billion.
In 2016, Johnson & Johnson’s annual gross profit was $50.101 billion.
Through the first 3 quarters of 2021, Johnson & Johnson’s gross profit was $47.071 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly gross profit was $16.088 billion.
In Q2 of 2021, Johnson & Johnson’s quarterly gross profit was $15.725 billion.
In Q1 of 2021, Johnson & Johnson’s quarterly gross profit was $15.258 billion.
In Q4 of 2020, Johnson & Johnson’s quarterly gross profit was $14.661 billion.
In Q3 of 2020, Johnson & Johnson’s quarterly gross profit was $14.110 billion.
In Q2 of 2020, Johnson & Johnson’s quarterly gross profit was $11.757 billion.
In Q1 of 2020, Johnson & Johnson’s quarterly gross profit was $13.629 billion.
Q3 2021’s gross profits for Johnson & Johnson, $16.088 billion, was a 14.02% increase year-over-year.
During the 12 months from Q3 2020 - Q3 2021, Johnson & Johnson’s gross profits were $61.732 billion, a 16.24% increase year-over-year.
Q3 2021’s gross profits were the highest Johnson & Johnson has ever had, $16.088 billion.

Johnson & Johnson Stock Price History

The all time high Johnson & Johnson (JNJ) closing price for a stock was $179.47 on 8/17/2021.

(year low - year high)

So far, in 2022, the Johnson & Johnson (JNJ) stock price per share ranged between $168.76 - $173.95.
In 2021, the Johnson & Johnson (JNJ) stock price per share ranged between $153.07 - $179.47.
In 2020, the Johnson & Johnson (JNJ) stock price per share ranged between $111.14 - $157.38.
In 2019, the Johnson & Johnson (JNJ) stock price per share ranged between $125.72 - $146.44.
In 2018, the Johnson & Johnson (JNJ) stock price per share ranged between $119.40 - $148.14.

(Average stock price per share)

So far, in 2022, the Johnson & Johnson (JNJ) average stock price per share is $171.4789.
In 2021, the Johnson & Johnson (JNJ) average stock price per share was $165.4633.
In 2020, the Johnson & Johnson (JNJ) average stock price per share was $145.8164.
In 2019, the Johnson & Johnson (JNJ) average stock price per share was $134.9359.
In 2018, the Johnson & Johnson (JNJ) average stock price per share was $133.0255.

(year open & year close)

In 2021, the Johnson & Johnson (JNJ) stock opened at $156.50 per share and closed at $171.07 per share, a 9.31% increase.
In 2020, the Johnson & Johnson (JNJ) stock opened at $145.97 per share and closed at $157.38 per share, a 7.82% increase.
In 2019, the Johnson & Johnson (JNJ) stock opened at $127.75 per share and closed at $145.87, a 14.18% increase.
In 2018, the Johnson & Johnson (JNJ) stock opened at $139.23 per share and closed at $129.05, a 7.31% decline.

Johnson & Johnson Market Cap

As of January 2022, Johnson & Johnson’s market cap is $441.85 billion.
As of January 2022, Johnson & Johnson’s is the world's 14th most valuable company with a market cap of $444.85 billion.
In 2021, Johnson & Johnson’s market cap was $442.93 billion, a 6.91% increase from 2020.
In 2020, Johnson & Johnson’s market cap was $414.30 billion, a 7.89% increase from 2019.
In 2019, Johnson & Johnson’s market cap was $384.00 billion, a 11.77% increase from 2018.
In 2018, Johnson & Johnson’s market cap was $343.57 billion, a 8.47% decline for 2017.
In 2017, Johnson & Johnson’s market cap was $375.36, a 19.76% increase from 2016.
In 2016, Johnson & Johnson’s market cap was $313.43 billion, a 10.28% increase from 2015.
Johnson & Johnson’s biggest market cap increase per year was in 2004, with $188.42 billion, a 22.89% increase from 2003.
Johnson & Johnson’s biggest market cap decline per year was in 2002, with $159.42 billion, a 11.47% decline from 2001.
In the Large Cap Pharmaceutical Companies, Johnson & Johnson is ranked #1 in terms of market cap, $441.85 billion.

Johnson & Johnson Operating Income

In 2020, Johnson & Johnson’s annual operating income was $16.497 billion, a 4.8% decline from 2019.
In 2019, Johnson & Johnson’s annual operating income was $17.328 billion, a 3.73% decline from 2018.
In 2018, Johnson & Johnson’s annual operating income was $17.999 billion, a 1.84% increase from 2017.
In 2017, Johnson & Johnson’s annual operating income was $17.673 billion.
In 2016, Johnson & Johnson’s annual operating income was $19.803 billion.
In 2014, Johnson & Johnson’s broke the $20B annual-operating-income threshold for the first time. Since then, they have yet to break that threshold again.
In Q3 of 2021, Johnson & Johnson’s quarterly operating income was $3.849 billion.
In Q2 of 2021, Johnson & Johnson’s quarterly operating income was $6.662 billion.
In Q1 of 2021, Johnson & Johnson’s quarterly operating income was $7.429 billion.
In Q4 of 2020, Johnson & Johnson’s quarterly operating income was $1.647 billion.
In Q3 of 2020, Johnson & Johnson’s quarterly operating income was 4.401 billion.
In Q2 of 2020, Johnson & Johnson’s quarterly operating income was $3.940 billion.
In Q1 of 2020, Johnson & Johnson’s quarterly operating income was $6.509 billion.
In Q4 of 2019, Johnson & Johnson’s quarterly operating income was $4.218 billion.
In Q3 of 2019, Johnson & Johnson’s quarterly operating income was $1.647 billion.
In Q2 of 2019, Johnson & Johnson’s quarterly operating income was $7.041 billion.
In Q1 of 2019, Johnson & Johnson’s quarterly operating income was $4.422 billion.
Johnson & Johnson’s highest quarterly operating income was Q1 of 2021, $7.429 billion.
Johnson & Johnson’s operating income for the first 3 quarters of 2021 was $17.940 billion.
Johnson & Johnson’s operating income during the 12 months between Q3 of 2020 - Q3 of 2021 was $19.587 billion, a 2.72% increase year-over-year.

Johnson & Johnson EBITDA

In 2020, Johnson & Johnson’s annual EBITDA was $24.04 billion, a 3.89% decline from 2019.
In 2019, Johnson & Johnson’s annual EBITDA was $25.012 billion, a 5.77% decline from 2018.
In 2018, Johnson & Johnson’s annual EBITDA was $26.544 billion, a 7.75% increase from 2017.
In 2017, Johnson & Johnson’s annual EBITDA was $24.634 billion.
In 2016, Johnson & Johnson’s annual EBITDA was $24.651 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly EBITDA was $5.696 billion, a 9.23% decline year-over-year.
In Q2 of 2021, Johnson & Johnson’s quarterly EBITDA was $8.553 billion.
In Q1 of 2021, Johnson & Johnson’s quarterly EBITDA was $9.401 billion.
In Q4 of 2020, Johnson & Johnson’s quarterly EBITDA was $3.687 billion.
In Q3 of 2020, Johnson & Johnson’s quarterly EBITDA was $6.275 billion.
In Q2 of 2020, Johnson & Johnson’s quarterly EBITDA was $5.730 billion.
In Q1 of 2020 Johnson & Johnson’s quarterly EBITDA was $8.348 billion.
During the 12 months between Q3 of 2020 - Q3 of 2021, Johnson & Johnson’s EBITDA was $27.337 billion, a 2.95% increase year-over-year.

Johnson & Johnson Net Income

During the first 3 quarters of 2021, Johnson & Johnson’s net income was $16.142 billion.
In 2020, Johnson & Johnson’s annual net income was $14.714 billion, a 2.68% decline from 2019.
In 2019, Johnson & Johnson’s annual net income was $15.119 billion, a 1.16% decline from2018.
In 2018, Johnson & Johnson’s annual net income was $15.297 billion, a 1076.69% increase from 2017.
In 2017, Johnson & Johnson’s annual net income was $1.3 billion.
In Q3 of 2021, Johnson & Johnson’s quarterly net income was $3.667 billion.
In Q2 of 2021, Johnson & Johnson’s quarterly net income was $6.278 billion.
In Q1 of 2021, Johnson & Johnson’s quarterly net income was $6.197 billion.
In Q4 of 2020, Johnson & Johnson’s quarterly net income was $1.738 billion.
In Q3 of 2020, Johnson & Johnson’s quarterly net income was $3.554 billion.
In Q2 of 2020, Johnson & Johnson’s quarterly net income was $3.626 billion.
In Q1 of 2020, Johnson & Johnson’s quarterly net income was $5.796 billion.
During the 12 months between Q3 of 2020 - Q3 of 2021, Johnson & Johnson’s net income was $17.880 billion, a 5.26% increase year-over-year.

Johnson & Johnson EPS

In 2020, Johnson & Johnson’s annual EPS was $5.51, a 2.13% decline from 2019.
In 2019, Johnson & Johnson’s annual EPS was $5.63, a 0.36% increase from 2018.
In 2018, Johnson & Johnson’s annual EPS was $5.61, a 1093.62% increase from 2017.
In 2017, Johnson & Johnson’s annual EPS was $0.47.
In Q3 of 2021, Johnson & Johnson’s quarterly EPS was $1.37, a 3.01% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s quarterly EPS was $2.35.
In Q1 of 2021, Johnson & Johnson’s quarterly EPS was $2.32.
In Q4 of 2020, Johnson & Johnson’s quarterly EPS was $0.65.
In Q3 of 2020, Johnson & Johnson’s quarterly EPS was $1.33.
In Q2 of 2020, Johnson & Johnson’s quarterly EPS was $1.36.
In Q1 of 2020, Johnson & Johnson’s quarterly EPS was $2.17.
During the 12 months between Q3 of 2020 - Q3 of 2021, Johnson & Johnson’s EPS was $6.69, a 5.19% increase year-over-year.

Johnson & Johnson Shares Outstanding

In 2020, Johnson & Johnson’s shares outstanding were 2.671 billion, a 0.51% decline from 2019.
In 2019, Johnson & Johnson’s shares outstanding were 2.684 billion, a 1.63% decline from 2018.
In 2018, Johnson & Johnson’s shares outstanding were 2.729 billion, a 0.6% decline from 2017.
In 2017, Johnson & Johnson’s shares outstanding were 2.745 billion.
In Q3 of 2021, Johnson & Johnson’s shares outstanding were 2.675 billion, a 0.21% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s shares outstanding were 2.672 billion.
In Q1 of 2021, Johnson & Johnson’s shares outstanding were 2.673 billion.
In Q4 of 2020, Johnson & Johnson’s shares outstanding were 2.671 billion.
In Q3 of 2020, Johnson & Johnson’s shares outstanding were 2.669 billion.
In Q2 of 2020, Johnson & Johnson’s shares outstanding were 2.666 billion.
In Q1 of 2020, Johnson & Johnson’s shares outstanding were 2.671 billion.

Chapter 2: Johnson & Johnson Assets & Liabilities Statistics

Johnson & Johnson Total Assets

In 2020, Johnson & Johnson’s total assets were $174.894 billion, a 10.88% increase from 2019.
In 2019, Johnson & Johnson’s total assets were $157.728 billion, a 3.12% from 2018.
In 2018, Johnson & Johnson’s total assets were $152.954 billion, a 2.76% decline from 2017.
In 2017, Johnson & Johnson’s total assets were $157.303 billion.
In Q3 of 2021, Johnson & Johnson’s total assets were $179.228 billion, a 5% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s total assets were $176.440 billion.
In Q1 of 2021, Johnson & Johnson’s total assets were $172.557 billion.
In Q4 of 2020, Johnson & Johnson’s total assets were $174.894 billion.
In Q3 of 2020, Johnson & Johnson’s total assets were $170.693 billion.
In Q2 of 2020, Johnson & Johnson’s total assets were $158.380 billion.
In Q1 of 2020, Johnson & Johnson’s total assets were $155.017 billion.

Johnson & Johnson Cash On Hand

In 2020, Johnson & Johnson’s cash on hand was $25.185 billion, a 30.58% increase from 2019.
In 2019, Johnson & Johnson’s cash on hand was $19.287 billion, a 2.03% decline from 2018.
In 2018, Johnson & Johnson’s cash on hand was $19.687 billion, a 7.6% increase from 2017.
In 2017, Johnson & Johnson’s cash on hand was $18.296 billion.
In Q3 of 2021, Johnson & Johnson’s cash on hand was $31.001 billion, a 0.71% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s cash on hand was $25.306 billion.
In Q1 of 2021, Johnson & Johnson’s cash on hand was $24.619 billion.
In Q4 of 2020, Johnson & Johnson’s cash on hand was $25.185 billion.
In Q3 of 2020, Johnson & Johnson’s cash on hand was $30.781 billion.
In Q2 of 2020, Johnson & Johnson’s cash on hand was $19.135 billion.
In Q1 of 2020, Johnson & Johnson’s cash on hand was $18.024 billion.

Johnson & Johnson Long Term Debt

In 2020, Johnson & Johnson’s long term debt was $32.635 billion, a 23.18% increase from 2019.
In 2019, Johnson & Johnson’s long term debt was $26.494 billion, a 4.3% decline from 2018.
In 2018, Johnson & Johnson’s long term debt was $27.684 billion, a 9.75% decline from 2017.
In 2017, Johnson & Johnson’s long term debt was $30.675 billion.
In Q3 of 2021, Johnson & Johnson’s long term debt was $30.130 billion, a 7.8% decline year-over-year.
In Q2 of 2021, Johnson & Johnson’s long term debt was $30.310 billion.
In Q1 of 2021, Johnson & Johnson’s long term debt was $30.263 billion.
In Q4 of 2020, Johnson & Johnson’s long term debt was $32.635 billion.
In Q3 of 2020, Johnson & Johnson’s long term debt was $32.680 billion.
In Q2 of 2020, Johnson & Johnson’s long term debt was $25.062 billion.
In Q1 of 2020, Johnson & Johnson’s long term debt was $25.393 billion.

Johnson & Johnson Total Liabilities

In 2020, Johnson & Johnson’s total liabilities were $111.616 billion, a 13.6 increase from 2019.
In 2019, Johnson & Johnson’s total liabilities were $98.257 billion, a 5.42% increase from 2018.
In 2018, Johnson & Johnson’s total liabilities were $93.202 billion, a 4.06% from 2017.
In 2017, Johnson & Johnson’s total liabilities were $97.143 billion.
In Q3 of 2021, Johnson & Johnson’s total liabilities were $108.956 billion, a 2.58% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s total liabilities were $106.860 billion.
In Q1 of 2021, Johnson & Johnson’s total liabilities were $106.723 billion.
In Q4 of 2020, Johnson & Johnson’s total liabilities were $111.616 billion.
In Q3 of 2020, Johnson & Johnson’s total liabilities were $106.220B
In Q2 of 2020, Johnson & Johnson’s total liabilities were $95.402 billion.
In Q1 of 2020, Johnson & Johnson’s total liabilities were $93.723 billion.

Johnson & Johnson Shareholder Equity

In 2020, Johnson & Johnson’s shareholder equity was $63.278 billion, a 6.4% increase from 2019.
In 2019, Johnson & Johnson’s shareholder equity was $59.471 billion, a 0.47% decline from 2018.
In 2018, Johnson & Johnson’s shareholder equity was $59.752 billion, a 0.68% decline from 2017.
In 2017, Johnson & Johnson’s shareholder equity was $60.160 billion.
In Q3 of 2021, Johnson & Johnson’s shareholder equity was $70.272 billion, a 8.99% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s shareholder equity was $69.580 billion.
In Q1 of 2021, Johnson & Johnson’s shareholder equity was $65.834 billion.
In Q4 of 2020, Johnson & Johnson’s shareholder equity was $63.278 billion.
In Q3 of 2020, Johnson & Johnson’s shareholder equity was $64.473 billion.
In Q2 of 2020, Johnson & Johnson’s shareholder equity was $62.978 billion.
In Q1 of 2020, Johnson & Johnson’s shareholder equity was $61.294 billion.

Chapter 3: Johnson & Johnson Margins Statistics

Johnson & Johnson Profit Margins

In 2020, Johnson & Johnson’s shareholder equity was $63.278 billion, a 6.4% increase from 2019.
In 2019, Johnson & Johnson’s shareholder equity was $59.471 billion, a 0.47% decline from 2018.
In 2018, Johnson & Johnson’s shareholder equity was $59.752 billion, a 0.68% decline from 2017.
In 2017, Johnson & Johnson’s shareholder equity was $60.160 billion.
In Q3 of 2021, Johnson & Johnson’s shareholder equity was $70.272 billion, a 8.99% increase year-over-year.
In Q2 of 2021, Johnson & Johnson’s shareholder equity was $69.580 billion.
In Q1 of 2021, Johnson & Johnson’s shareholder equity was $65.834 billion.
In Q4 of 2020, Johnson & Johnson’s shareholder equity was $63.278 billion.
In Q3 of 2020, Johnson & Johnson’s shareholder equity was $64.473 billion.
In Q2 of 2020, Johnson & Johnson’s shareholder equity was $62.978 billion.
In Q1 of 2020, Johnson & Johnson’s shareholder equity was $61.294 billion.

Johnson & Johnson Gross Margins

In Q3 of 2021, Johnson & Johnson’s gross margin was 67.51%.
In Q2 of 2021, Johnson & Johnson’s gross margin was 67.00%.
In Q1 of 2021, Johnson & Johnson’s gross margin was 66.24%.
In Q4 of 2020, Johnson & Johnson’s gross margin was 65.58%.
In Q3 of 2020, Johnson & Johnson’s gross margin was 65.68%.
In Q2 of 2020, Johnson & Johnson’s gross margin was 65.66%.
In Q1 of 2020, Johnson & Johnson’s gross margin was 66.15%.

Johnson & Johnson Operating Margins

In Q3 of 2021, Johnson & Johnson’s operating margin was 21.42%.
In Q2 of 2021, Johnson & Johnson’s operating margin was 22.58%.
In Q1 of 2021, Johnson & Johnson’s operating margin was 20.68%.
In Q4 of 2020, Johnson & Johnson’s operating margin was 19.98%.
In Q3 of 2020, Johnson & Johnson’s operating margin was 23.58%.
In Q2 of 2020, Johnson & Johnson’s operating margin was 20.27%.
In Q1 of 2020, Johnson & Johnson’s operating margin was 23.47%.

Johnson & Johnson EBITDA Margins

In Q3 of 2021, Johnson & Johnson’s EBITDA margin was 29.89%.
In Q2 of 2021, Johnson & Johnson’s EBITDA margin was 31.30%.
In Q1 of 2021, Johnson & Johnson’s EBITDA margin was 29.80%.
In Q4 of 2020, Johnson & Johnson’s EBITDA margin was 29.11%.
In Q3 of 2020, Johnson & Johnson’s EBITDA margin was 32.84%.
In Q2 of 2020, Johnson & Johnson’s EBITDA margin was 29.55%.
In Q1 of 2020, Johnson & Johnson’s EBITDA margin was 32.61%.

Johnson & Johnson Pre-Tax Profit Margins

In Q3 of 2021, Johnson & Johnson’s pre-tax profit margin was 21.42%.
In Q2 of 2021, Johnson & Johnson’s pre-tax profit margin was 22.58%.
In Q1 of 2021, Johnson & Johnson’s pre-tax profit margin was 20.68%.
In Q4 of 2020, Johnson & Johnson’s pre-tax profit margin was 19.98%.
In Q3 of 2020, Johnson & Johnson’s pre-tax profit margin was 23.58%.
In Q2 of 2020, Johnson & Johnson’s pre-tax profit margin was 20.27%.
In Q1 of 2020, Johnson & Johnson’s pre-tax profit margin was 23.47%.

Johnson & Johnson Net Margins

In Q3 of 2021, Johnson & Johnson’s net profit margin was 19.55%.
In Q2 of 2021, Johnson & Johnson’s net profit margin was 19.92%.
In Q1 of 2021, Johnson & Johnson’s net profit margin was 17.95%.
In Q4 of 2020, Johnson & Johnson’s net profit margin was 17.82%.
In Q3 of 2020, Johnson & Johnson’s net profit margin was 21.01%.
In Q2 of 2020, Johnson & Johnson’s net profit margin was 18.86%.
In Q1 of 2020, Johnson & Johnson’s net profit margin was 20.75%.

Chapter 4: Johnson & Johnson Price Ratios

Johnson & Johnson PE Ratio

As of 01/14/2022, Johnson & Johnson’s PE ratio was 25.09.
In Q3 of 2021, Johnson & Johnson’s PE ratio was 23.98.
In Q2 of 2021, Johnson & Johnson’s PE ratio was 24.46.
In Q1 of 2021, Johnson & Johnson’s PE ratio was 28.50.
In Q4 of 2020, Johnson & Johnson’s PE ratio was 27.86.
In Q3 of 2020, Johnson & Johnson’s PE ratio was 22.67.
In Q2 of 2020, Johnson & Johnson’s PE ratio was 19.78.
In Q1 of 2020, Johnson & Johnson’s PE ratio was 16.57.

Johnson & Johnson P/S Ratio

As of 01/14/2022, Johnson & Johnson’s P/S ratio was 4.91.
In Q3 of 2021, Johnson & Johnson’s P/S ratio was 4.69.
In Q2 of 2021, Johnson & Johnson’s P/S ratio was 4.87.
In Q1 of 2021, Johnson & Johnson’s P/S ratio was 5.11.
In Q4 of 2020, Johnson & Johnson’s P/S ratio was 4.96.
In Q3 of 2020, Johnson & Johnson’s P/S ratio was 4.77.
In Q2 of 2020, Johnson & Johnson’s P/S ratio was 4.49.
In Q1 of 2020, Johnson & Johnson’s P/S ratio was 4.06.

Johnson & Johnson Price/Book Ratio

As of 01/14/2022, Johnson & Johnson’s P/B ratio was 6.29.
In Q3 of 2021, Johnson & Johnson’s P/B ratio was 6.01.
In Q2 of 2021, Johnson & Johnson’s P/B ratio was 6.15.
In Q1 of 2021, Johnson & Johnson’s P/B ratio was 6.45.
In Q4 of 2020, Johnson & Johnson’s P/B ratio was 6.39.
In Q3 of 2020, Johnson & Johnson’s P/B ratio was 5.89.
In Q2 of 2020, Johnson & Johnson’s P/B ratio was 5.66.
In Q1 of 2020, Johnson & Johnson’s P/B ratio was 5.38.

Johnson & Johnson Price-FCF Ratio

As of 01/14/2022, Johnson & Johnson’s price to FCF ratio was 19.24.
In Q3 of 2021, Johnson & Johnson’s price to FCF ratio was 18.39.
In Q2 of 2021, Johnson & Johnson’s price to FCF ratio was 18.55.
In Q1 of 2021, Johnson & Johnson’s price to FCF ratio was 19.81.
In Q4 of 2020, Johnson & Johnson’s price to FCF ratio was 20.00.
In Q3 of 2020, Johnson & Johnson’s price to FCF ratio was 20.87.
In Q2 of 2020, Johnson & Johnson’s price to FCF ratio was 20.35.
In Q1 of 2020, Johnson & Johnson’s price to FCF ratio was 14.74.

Chapter 5: Johnson & Johnson Other Ratios

Johnson & Johnson Current Ratio

In Q3 of 2021, Johnson & Johnson’s current ratio was 1.34.
In Q2 of 2021, Johnson & Johnson’s current ratio was 1.39.
In Q1 of 2021, Johnson & Johnson’s current ratio was 1.28.
In Q4 of 2020, Johnson & Johnson’s current ratio was 1.21.
In Q3 of 2020, Johnson & Johnson’s current ratio was 1.48.
In Q2 of 2020, Johnson & Johnson’s current ratio was 1.25.
In Q1 of 2020, Johnson & Johnson’s current ratio was 1.31.

Johnson & Johnson Quick Ratio

In Q3 of 2021, Johnson & Johnson’s quick ratio value was 1.11.
In Q2 of 2021, Johnson & Johnson’s quick ratio value was 1.13.
In Q1 of 2021, Johnson & Johnson’s quick ratio value was 1.04.
In Q4 of 2020, Johnson & Johnson’s quick ratio value was 0.99.
In Q3 of 2020, Johnson & Johnson’s quick ratio value was 1.24.
In Q2 of 2020, Johnson & Johnson’s quick ratio value was 0.99.
In Q1 of 2020, Johnson & Johnson’s quick ratio value was 1.05.

Johnson & Johnson Debt/Equity Ratio

In Q3 of 2021, Johnson & Johnson’s debt to equity ratio value was 1.55.
In Q2 of 2021, Johnson & Johnson’s debt to equity ratio value was 1.54.
In Q1 of 2021, Johnson & Johnson’s debt to equity ratio value was 1.62.
In Q4 of 2020, Johnson & Johnson’s debt to equity ratio value was 1.76.
In Q3 of 2020, Johnson & Johnson’s debt to equity ratio value was 1.65.
In Q2 of 2020, Johnson & Johnson’s debt to equity ratio value was 1.52.
In Q1 of 2020, Johnson & Johnson’s debt to equity ratio value was 1.53.

Johnson & Johnson ROE

In Q3 of 2021, Johnson & Johnson’s return on equity (ROE) value was 26.59%.
In Q2 of 2021, Johnson & Johnson’s return on equity (ROE) value was 27.01%.
In Q1 of 2021, Johnson & Johnson’s return on equity (ROE) value was 23.57%.
In Q4 of 2020, Johnson & Johnson’s return on equity (ROE) value was 23.35%.
In Q3 of 2020, Johnson & Johnson’s return on equity (ROE) value was 27.37%.
In Q2 of 2020, Johnson & Johnson’s return on equity (ROE) value was 25.10%.
In Q1 of 2020, Johnson & Johnson’s return on equity (ROE) value was 28.64%.

Johnson & Johnson ROA

In Q3 of 2021, Johnson & Johnson’s return on assets (ROA) value was 10.17%.
In Q2 of 2021, Johnson & Johnson’s return on assets (ROA) value was 10.23%.
In Q1 of 2021, Johnson & Johnson’s return on assets (ROA) value was 8.94%.
In Q4 of 2020, Johnson & Johnson’s return on assets (ROA) value was 8.93%.
In Q3 of 2020, Johnson & Johnson’s return on assets (ROA) value was 10.59%.
In Q2 of 2020, Johnson & Johnson’s return on assets (ROA) value was 9.69%.
In Q1 of 2020, Johnson & Johnson’s return on assets (ROA) value was 11.01%.

Johnson & Johnson ROI

In Q3 of 2021, Johnson & Johnson’s return on investment (ROI) value was 19.97%.
In Q2 of 2021, Johnson & Johnson’s return on investment (ROI) value was 20.71%.
In Q1 of 2021, Johnson & Johnson’s return on investment (ROI) value was 18.47%.
In Q4 of 2020, Johnson & Johnson’s return on investment (ROI) value was 17.94%.
In Q3 of 2020, Johnson & Johnson’s return on investment (ROI) value was 21.31%.
In Q2 of 2020, Johnson & Johnson’s return on investment (ROI) value was 18.87%.
In Q1 of 2020, Johnson & Johnson’s return on investment (ROI) value was 22.43%.

Johnson & Johnson Return On Tangible Equity

In Q3 of 2021, Johnson & Johnson’s return on tangible equity value was -92.84%.
In Q2 of 2021, Johnson & Johnson’s return on tangible equity value was -87.95%.
In Q1 of 2021, Johnson & Johnson’s return on tangible equity value was -73.16%.
In Q4 of 2020, Johnson & Johnson’s return on tangible equity value was -72.49%.
In Q3 of 2020, Johnson & Johnson’s return on tangible equity value was -88.83%.
In Q2 of 2020, Johnson & Johnson’s return on tangible equity value was -73.55%.
In Q1 of 2020, Johnson & Johnson’s return on tangible equity value was -79.42%.

Chapter 6: Johnson & Johnson Employees

In 2020, Johnson & Johnson had 134,500 employees.
In 2019, Johnson & Johnson had 132,200 employees.
In 2018, Johnson & Johnson had 135,100 employees.

Conclusion

Johnson & Johnson is a corporation in the Large Cap Pharmaceutical Industry. They manufacture health care products and provide services for the consumer, pharmaceutical, and medical device markets.

Johnson & Johnson sells both over-the-counter and prescription products. They also provide surgical implants in countries all over the world.

Johnson & Johnson was founded, and is still based in New Brunswick, New Jersey, USA.

The company is publicly owned with more than 260 operating companies in more than 60 countries.

Learn more about statistics on Johnson & Johnson's biggest competitor, Pfizer.